Phone-Based Interventions in Adolescent Psychiatry: A Perspective and Proof of Concept Pilot Study With a Focus on Depression and Autism

摘要: Background: Telemedicine has emerged as an innovative platform to diagnose and treat psychiatric disorders in a cost-effective fashion. Previous studies have laid the functional framework for monitoring treating child electronically using videoconferencing, mobile phones (smartphones), Web-based apps. However, phone call text message (short service, SMS) interventions adolescent psychiatry are less studied than other electronic platforms. Further investigations on development of these needed. Objective: The aim this paper was explore utility describe user feedback-driven iterative design process systems. Methods: We developed automated both depression (EpxDepression) autism spectrum disorder (ASD; EpxAutism) conducted 2 pilot each intervention (N=3 N=6, respectively). were prescribed by accessible patients’ healthcare providers. EpxDepression EpxAutism utilized system triage patients into 1 3 risk categories based their responses alerted providers directly via online interface when met provider-specified criteria. Rapid text-based feedback from participants interviews with allowed quick cycles improve interventions. Results: Patients had high weekly response rates (100% over 4 months), but exhibited fatigue daily prompts mean (SD) overall 66.3% (21.6%) 64.7% (8.2%) mood sleep questionnaires, respectively. In contrast, parents displayed 85%, respectively, months) that did not decay significantly time. Monthly participant surveys (7 surveys) (18 preliminarily indicated interventions, messages constituted “perfect amount” contact EpxAutism, EpxDepression, improved patient communication Notably, detected thoughts self-harm before case managers or caregivers aware such ideation. Conclusions: Text-message can provide engaging method track symptoms, behavior, ideation Following collection data patients, larger already underway validate clinical EpxAutism. Trial Registration: Clinicaltrials.gov NCT03002311; https://clinicaltrials.gov/ct2/show/NCT03002311 (Archived WebCite at http://www.webcitation.org/6qQtlCIS0) [JMIR Res Protoc 2017;6(6):e114]